Thomas; Sheela A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thomas; Sheela A..The latest application filed is for "1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors".

Company Profile

0.13.17

Thomas; Sheela A. - Libertyville IL
Thomas; Sheela A. - Vernon Hills IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1h-benzimidazole-4-carboxamides Substituted With Phenyl At The 2-position Are Potent Parp Inhibitors App 20140296235 - Penning; Thomas D. ; et al.	2014-10-02
1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors Grant 8,697,736 - Penning , et al. April 15, 2	2014-04-15
Potent PARP inhibitors Grant 8,183,250 - Penning , et al. May 22, 2	2012-05-22
Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors Grant 7,999,117 - Giranda , et al. August 16, 2	2011-08-16
Biaryl carboxylic acid apoptosis promoters Grant 7,989,656 - Wendt , et al. August 2, 2	2011-08-02
Apoptosis Promoters App 20100234456 - Wendt; Michael D. ; et al.	2010-09-16
N-acylsulfonamide apoptosis promoters Grant 7,754,886 - Augeri , et al. July 13, 2	2010-07-13
Apoptosis promoters Grant 7,750,004 - Wendt , et al. July 6, 2	2010-07-06
Potent Parp Inhibitors App 20090298858 - Penning; Thomas D. ; et al.	2009-12-03
Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors Grant 7,595,406 - Penning , et al. September 29, 2	2009-09-29
Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20090186877 - Giranda; Vincent L. ; et al.	2009-07-23
N-acylsulfonamide Apoptosis Promoters App 20090137585 - Augeri; David J. ; et al.	2009-05-28
N-acylsulfonamide apoptosis promoters Grant 7,504,512 - Augeri , et al. March 17, 2	2009-03-17
Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors Grant 7,462,724 - Penning , et al. December 9, 2	2008-12-09
Pim Kinase Inhibitors As Cancer Chemotherapeutics App 20080161578 - Penning; Thomas D. ; et al.	2008-07-03
Potent PARP Inhibitors App 20080015182 - Penning; Thomas D. ; et al.	2008-01-17
Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20070270476 - Penning; Thomas D. ; et al.	2007-11-22
Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20070259937 - Giranda; Vincent L. ; et al.	2007-11-08
1h-benzimidazole-4-carboxamides Substituted With Phenyl At The 2-position Are Potent Parp Inhibitors App 20070179136 - Penning; Thomas D. ; et al.	2007-08-02
Apoptosis promoters App 20070135392 - Wendt; Michael D. ; et al.	2007-06-14
Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20070112047 - Penning; Thomas D. ; et al.	2007-05-17
Kinase inhibitors Grant 6,831,175 - Li , et al. December 14, 2	2004-12-14
N-acylsulfonamide apoptosis promoters App 20040192681 - Augeri, David J. ; et al.	2004-09-30
N-acylsulfonamide apoptosis promoters Grant 6,720,338 - Augeri , et al. April 13, 2	2004-04-13
Kinase inhibitors App 20030199511 - Li, Qun ; et al.	2003-10-23
Kinase inhibitors App 20030187026 - Li, Qun ; et al.	2003-10-02
N-Acylsulfonamide apoptosis promoters App 20020086887 - Augeri, David J. ; et al.	2002-07-04
N-acylsulfonamide apoptosis promoters App 20020055631 - Augeri, David J. ; et al.	2002-05-09
Dopaminergic compounds Grant 4,994,486 - Schoenleber , et al. February 19, 1	1991-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.